The determination of the factors impacting on in-hospital mortality in patients with acute heart failure in a tertiary referral center

被引:0
作者
Zoghi, Mehdi [1 ]
Duygu, Hama [1 ]
Gungor, Hasan [1 ]
Nalbantgil, Sanem [1 ]
Yilmaz, Guelsuem Meral [1 ]
Tuluce, Kamil [1 ]
Ozerkan, Filiz [1 ]
Akilli, Azem [1 ]
Akin, Mustafa [1 ]
机构
[1] Ege Univ, Tip Fak, Kardiyol Anabilim Dali, Izmir, Turkey
关键词
acute heart failure; in-hospital mortality; logistic regression analysis;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Despite impressive advances in therapeutics in the last years, acute heart failure (AHF) remains a major cause of cardiovascular morbidity and mortality. Patients hospitalized because of heart failure (HF), irrespective of left ventricular systolic function, represent a high-risk population with limited short-term prognosis. A substantial component of HF-related mortality occurs during a hospital stay. In this study, we aimed to determine the factors impacting on in-hospital mortality in patients with AHF. Methods: During a 15-month period (December 2005-March 2007), 85 consecutive patients with (mean age: 64 8 years, male: 54%) an episode of AHF were included in this study. The effect of demographic, clinical, electrocardiographic, and echocardiographic characteristics, laboratory findings on in-hospital mortality were evaluated retrospectively. Results: Of 85 patients 24.7% of patients had new-onset HE Coronary artery disease (61%) was the most common underlying disease. The 44.7% of patients had hypertension, 37.6% had diabetes mellitus, 21% had chronic renal failure and 16.4% had chronic obstructive pulmonary disease. Left ventricular ejection fraction was 35 +/- 7%. In-hospital mortality rate was found as 11.7% (10 patients).The major cause of mortality was the progression of HF to cardiogenic shock in 60% of deaths. In comparison with surviving patients in terms of the clinical, demographic, electrocardiographic, and laboratory characteristics and left and right ventricular functions, patients died during hospitalization had higher blood urea nitrogen (45 +/- 20 mg/dl vs. 36 +/- 12 mg/dI, p=0.04), higher creatinine level (2.2 +/- 0.8 mg/dI vs. 1.1 +/- 0.5 mg/dI, p=0.001), and wider (IRS duration (130 +/- 13 ms vs. 116 +/- 18 ms, p=0.04) whereas they had lower plasma sodium level (128 5 mmol/l vs. 135 +/- 9 mmol/l, p=0.02) and systolic blood pressure (p=0.01). Logistic regression analysis revealed that plasma creatinine level (OR 1.5, 95% Cl 1.2 to 2.1, p=0.01), blood urea nitrogen (OR 2.1, 95% CI 1.8 to 3.1, p=0.001), plasma sodium level (OR 1.3, 95% CI 1.1 to 1.7, p=0.02), and systolic blood pressure (OR 2.2, 95% CI 1.9 to 2.8, p=0.01) were the independent predictors of in-hospital mortality. Conclusion: In-hospital mortality increases in patients who had lower systolic blood pressure, lower plasma sodium level, and renal dysfunction on admission.
引用
收藏
页码:255 / 259
页数:5
相关论文
共 36 条
[11]  
Duygu Hamza, 2005, Anadolu Kardiyol Derg, V5, P305
[12]  
Fonarow G, 2005, J AM COLL CARDIOL, V45, p345A
[13]   Risk stratification for in-hospital mortality in acutely decompensated heart failure - Classification and regression tree analysis [J].
Fonarow, GC ;
Adams, KF ;
Abraham, WT ;
Yancy, CW ;
Boscardin, WJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (05) :572-580
[14]   Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure [J].
Fonarow, Gregg C. ;
Peacock, William F. ;
Phillips, Christopher O. ;
Givertz, Michael M. ;
Lopatin, Margarita .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (19) :1943-1950
[15]   SURVIVAL OF HEART-FAILURE PATIENTS WITH PRESERVED VERSUS IMPAIRED SYSTOLIC FUNCTION - THE PROGNOSTIC IMPLICATION OF BLOOD-PRESSURE [J].
GHALI, JK ;
KADAKIA, S ;
BHATT, A ;
COOPER, R ;
LIAO, YL .
AMERICAN HEART JOURNAL, 1992, 123 (04) :993-997
[16]   Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of vasopressin antagonism in heart failure: Outcome Study with Tolvaptan (EVEREST) [J].
Gheorghiade, M ;
Orlandi, C ;
Burnett, JC ;
Demets, D ;
Grinfeld, L ;
Maggioni, A ;
Swedberg, K ;
Udelson, JE ;
Zannad, F ;
Zimmer, C ;
Konstam, MA .
JOURNAL OF CARDIAC FAILURE, 2005, 11 (04) :260-269
[17]   Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995 [J].
Haldeman, GA ;
Croft, JB ;
Giles, WH ;
Rashidee, A .
AMERICAN HEART JOURNAL, 1999, 137 (02) :352-360
[18]   Renal function, neurohormonal activation, and survival in patients with chronic heart failure [J].
Hillege, HL ;
Girbes, ARJ ;
de Kam, PJ ;
Boomsma, F ;
de Zeeuw, D ;
Charlesworth, A ;
Hampton, JR ;
van Veldhuisen, DJ .
CIRCULATION, 2000, 102 (02) :203-+
[19]   Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure [J].
Horwich, TB ;
Fonarow, GC ;
Hamilton, MA ;
MacLellan, WR ;
Borenstein, J .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (11) :1780-1786
[20]   Prognosis and determinants of survival in patients newly hospitalized for heart failure - A population-based study [J].
Jong, P ;
Vowinckel, E ;
Liu, PP ;
Gong, YY ;
Tu, JV .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (15) :1689-1694